- Home
- CGEM vs EGY Comparison
CGEM vs EGY Comparison
Compare CGEM & EGY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGEM
- EGY
- Stock Information
- Founded
- CGEM 2016
- EGY 1985
- Country
- CGEM United States
- EGY United States
- Employees
- CGEM N/A
- EGY N/A
- Industry
- CGEM Biotechnology: Pharmaceutical Preparations
- EGY Oil & Gas Production
- Sector
- CGEM Health Care
- EGY Energy
- Exchange
- CGEM Nasdaq
- EGY Nasdaq
- Market Cap
- CGEM 366.3M
- EGY 399.3M
- IPO Year
- CGEM 2021
- EGY N/A
- Fundamental
- Price
- CGEM $5.95
- EGY $4.05
- Analyst Decision
- CGEM Strong Buy
- EGY
- Analyst Count
- CGEM 7
- EGY 0
- Target Price
- CGEM $26.00
- EGY N/A
- AVG Volume (30 Days)
- CGEM 789.8K
- EGY 707.1K
- Earning Date
- CGEM 11-06-2025
- EGY 11-10-2025
- Dividend Yield
- CGEM N/A
- EGY 6.17%
- EPS Growth
- CGEM N/A
- EGY N/A
- EPS
- CGEM N/A
- EGY 0.37
- Revenue
- CGEM N/A
- EGY $469,277,000.00
- Revenue This Year
- CGEM N/A
- EGY N/A
- Revenue Next Year
- CGEM N/A
- EGY $23.20
- P/E Ratio
- CGEM N/A
- EGY $11.00
- Revenue Growth
- CGEM N/A
- EGY N/A
- 52 Week Low
- CGEM $5.68
- EGY $3.00
- 52 Week High
- CGEM $17.98
- EGY $6.45
- Technical
- Relative Strength Index (RSI)
- CGEM 39.45
- EGY 50.52
- Support Level
- CGEM $5.68
- EGY $3.87
- Resistance Level
- CGEM $6.13
- EGY $4.15
- Average True Range (ATR)
- CGEM 0.29
- EGY 0.14
- MACD
- CGEM 0.03
- EGY -0.03
- Stochastic Oscillator
- CGEM 28.42
- EGY 33.33
About CGEM Cullinan Oncology Inc.
Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.
About EGY VAALCO Energy Inc.
VAALCO Energy Inc is an independent energy company operating in the United States. It is principally engaged in the acquisition, exploration, development, and production of crude oil and natural gas. The company operates through geographical segments namely Gabon, Egypt, Canada, Equatorial Guinea, and Cote d'Ivoire. The company generates maximum revenue from the Gabon segment.